Supreme Court decision could free up telemedicine practices

A recent Supreme Court ruling could potentially allow telemedicine providers to practice without potentially having their legitimacy challenged by state medical licensing boards.

Advertisement

The case itself, North Carolina Board of Dental Examiners v. Federal Trade Commission, has little to do with digital health. The Supreme Court ruled 6-3 that the NCBD could not prohibit non-dentists from offering teeth-whitening services because prohibiting them from practicing violated anti-trust laws, according to MobiHealthNews.

However, this could aid telemedicine providers because they face similar opposition from existing state medical associations. The precedent set by the teeth whitening case could allow telehealth companies to object when state licensing boards block them from offering their services, according to the report.

States are increasingly passing legislation that expands telemedicine parity, some including provisions that require licensing boards to recognize telemedicine. The Federation of State Medical Boards proposed a compact last summer that would allow physicians to be licensed in multiple states, allowing for easier use of telemedicine among states, according to the report.

The ruling may not specifically address telemedicine, but its precedent may make telemedicine providers more able to practice because the state medical boards cannot explicitly approve or deny their right to practice without state government oversight, according to the report.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.